129 related articles for article (PubMed ID: 11181276)
1. [Microsatellite analysis in the diagnosis of second primary tumor of lung in patient with head neck squamous cell carcinoma].
León L; Forteza J; Barros F; López R
Med Clin (Barc); 2001 Jan; 116(2):75. PubMed ID: 11181276
[No Abstract] [Full Text] [Related]
2. Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma.
Blons H; Cabelguenne A; Carnot F; Laccourreye O; de Waziers I; Hamelin R; Brasnu D; Beaune P; Laurent-Puig P
Int J Cancer; 1999 Aug; 84(4):410-5. PubMed ID: 10404095
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?
Geurts TW; Nederlof PM; van den Brekel MW; van't Veer LJ; de Jong D; Hart AA; van Zandwijk N; Klomp H; Balm AJ; van Velthuysen ML
Clin Cancer Res; 2005 Sep; 11(18):6608-14. PubMed ID: 16166439
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
Leong PP; Rezai B; Koch WM; Reed A; Eisele D; Lee DJ; Sidransky D; Jen J; Westra WH
J Natl Cancer Inst; 1998 Jul; 90(13):972-7. PubMed ID: 9665144
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability as biomarker for risk of multiple primary malignancies of the upper aerodigestive tract.
Sardi I; Franchi A; Bocciolini C; Mechi C; Frittelli A; Bruschini L; Gallo O
Oncol Rep; 2001; 8(2):393-9. PubMed ID: 11182062
[TBL] [Abstract][Full Text] [Related]
6. An allelotype of squamous carcinoma of the head and neck using microsatellite markers.
Ah-See KW; Cooke TG; Pickford IR; Soutar D; Balmain A
Cancer Res; 1994 Apr; 54(7):1617-21. PubMed ID: 8137268
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Ali MA; Beder L; Tamamura R; Katase N; Tominaga S; Yamanaka N; Shimizu K; Nagatsuka H
Cancer Invest; 2009 Jul; 27(6):661-8. PubMed ID: 19488910
[TBL] [Abstract][Full Text] [Related]
8. No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.
Jefferies S; Edwards SM; Hamoudi RA; A'Hern R; Foulkes W; Goldgar D; Eeles R;
Br J Cancer; 2001 Nov; 85(9):1383-6. PubMed ID: 11720478
[TBL] [Abstract][Full Text] [Related]
9. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
10. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships.
Califano J; Leong PL; Koch WM; Eisenberger CF; Sidransky D; Westra WH
Clin Cancer Res; 1999 Jul; 5(7):1862-7. PubMed ID: 10430093
[TBL] [Abstract][Full Text] [Related]
11. Multiple head and neck tumours and their genetic relationship.
Allegra E; Baudi F; La Boria A; Fagiani F; Garozzo A; Costanzo FS
Acta Otorhinolaryngol Ital; 2009 Oct; 29(5):237-41. PubMed ID: 20162022
[TBL] [Abstract][Full Text] [Related]
12. The origins of multiple squamous cell carcinomas in the aerodigestive tract.
van Oijen MG; Leppers Vd Straat FG; Tilanus MG; Slootweg PJ
Cancer; 2000 Feb; 88(4):884-93. PubMed ID: 10679659
[TBL] [Abstract][Full Text] [Related]
13. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer.
Takebayashi S; Hickson A; Ogawa T; Jung KY; Mineta H; Ueda Y; Grénman R; Fisher SG; Carey TE
Genes Chromosomes Cancer; 2004 Oct; 41(2):145-54. PubMed ID: 15287027
[TBL] [Abstract][Full Text] [Related]
14. Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas.
Choi HR; Sturgis EM; Rosenthal DI; Luna MA; Batsakis JG; El-Naggar AK
Am J Surg Pathol; 2003 Sep; 27(9):1216-20. PubMed ID: 12960805
[TBL] [Abstract][Full Text] [Related]
15. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.
Lee DJ; Koch WM; Yoo G; Lango M; Reed A; Califano J; Brennan JA; Westra WH; Zahurak M; Sidransky D
Clin Cancer Res; 1997 Apr; 3(4):501-5. PubMed ID: 9815712
[TBL] [Abstract][Full Text] [Related]
16. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma.
Acha-Sagredo A; Ruesga MT; Rodriguez C; Aguirregaviria JI; de Pancorbo MM; Califano JA; Aguirre JM
Oral Oncol; 2009 Aug; 45(8):661-4. PubMed ID: 19027352
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral genetic heterogeneity in primary head and neck squamous carcinoma using microsatellite markers.
el-Naggar AK; Hurr K; Luna MA; Goepfert H; Hong WK; Batsakis JG
Diagn Mol Pathol; 1997 Dec; 6(6):305-8. PubMed ID: 9559289
[TBL] [Abstract][Full Text] [Related]
18. Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung.
Endo C; Sagawa M; Sato M; Chen Y; Sakurada A; Aikawa H; Takahashi S; Usuda K; Saito Y; Fujimura S
Br J Cancer; 1998 Sep; 78(5):612-5. PubMed ID: 9744500
[TBL] [Abstract][Full Text] [Related]
19. Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population.
Dasgupta S; Mukherjee N; Roy S; Roy A; Sengupta A; Roychowdhury S; Panda CK
Oral Oncol; 2002 Jan; 38(1):6-15. PubMed ID: 11755815
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.
Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ
Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
